* Asian positive factors led by SE Asia

* U.S. and European futures in detrimental territory

* Oil strengthens on vaccine optimism

* Greenback weakens on rising case numbers

* Asian inventory markets: https://tmsnrt.rs/2zpUAr4

By Alun John and Chibuike Oguh

HONG KONG/NEW YORK, Nov 17 (Reuters) – Asian shares held positive factors and moved tentatively additional into report territory on Tuesday, after U.S. benchmarks had been pepped up by information of one other promising coronavirus vaccine, although futures indicated the rally might stall in European hours.

Investor sentiment was given a lift when Moderna Inc stated its experimental COVID-19 vaccine was 94.5% efficient in stopping an infection based mostly on interim late-stage information.

The Cambridge, Massachusetts-based agency grew to become the second drugmaker, after Pfizer Inc, to announce promising trial information within the improvement of a vaccine. Its shares gained 9.6% on the day.

MSCI’s broadest index of Asia-Pacific shares outdoors Japan gained 0.17% on Tuesday, a day after hitting its highest degree since launching in 1987.

The MSCI World Index of worldwide shares which additionally hit a report excessive on Monday, ticked increased nonetheless within the Asian session.

“The market is assuming that we will see the tip of the tunnel, that in 2022 a big a part of the world’s inhabitants will begin to obtain entry to vaccines,” stated Herald van der Linde, HSBC’s head of fairness technique for Asia Pacific.

There have been preliminary indications that this was sparking a change in buyers’ attitudes, he added.

“The vaccine may mark a normalisation in markets whereby individuals begin to rotate and transfer out of shares and markets which have rallied, and transfer into ones that haven’t accomplished as properly,” van der Linde stated, citing some markets in Southeast Asia.

Asia positive factors on Tuesday had been led by benchmarks in Singapore and Indonesia which each rose round 1%, whereas Hong Kong rose 0.1% and Australia’s S&P/ASX 200 was up 0.23%.

Japan’s Nikkei 225 rose 0.24% after hitting a 29-year excessive the day earlier than, however Chinese language blue chips dropped as current bond defaults hit sentiment.

Story continues

Nevertheless, regardless of a gradual if muted efficiency in Asian buying and selling, futures predicted a turnaround later within the day.

S&P 500 futures dropped 0.44%, European EuroSTOXX 50 futures fell 0.55% and FTSE futures fell 0.4% late within the Asia session.

The optimistic vaccine information helped oil costs maintain onto Monday’s positive factors.

U.S. crude on Tuesday firmed 0.56% to $41.57 per barrel after rising 3.02% on Monday, and Brent gained 0.7% after a 2.43% soar the day earlier than.

In foreign money markets, China’s central financial institution on Tuesday lifted its official yuan midpoint to the very best in practically 29 months, underpinned by stable positive factors in spot costs a day earlier on the again of sturdy financial information.

The vaccine information helped the risk-friendly Australian greenback , which climbed to a one-week excessive in opposition to its U.S. counterpart. Rising virus case numbers in america clouded views on the greenback, which dropped in opposition to a basket of main currencies.

U.S. Treasury yields rose on Monday and into Tuesday and the yield curve steepened within the wake of the vaccine developments. The yield on Benchmark 10-year notes was final at 0.9127%, from 0.893% late on Friday.

(Reporting by Alun John in Hong Kong and Chibuike Oguh in New York; Enhancing by Sam Holmes and Stephen Coates)